Suppr超能文献

肝移植术后肝动脉狭窄的初次支架置入:提高原发性通畅率和再介入率。

Primary Stent Placement for Hepatic Artery Stenosis After Liver Transplantation: Improving Primary Patency and Reintervention Rates.

机构信息

Divisions of Vascular and Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Divisions of Transplant Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

出版信息

Liver Transpl. 2018 Oct;24(10):1377-1383. doi: 10.1002/lt.25292.

Abstract

Recent studies have reported high rates of reintervention after primary stenting for hepatic artery stenosis (HAS) due to the loss of primary patency. The aims of this study were to evaluate the outcomes of primary stenting after HAS in a large cohort with longterm follow-up. After institutional review board approval, all patients undergoing liver transplantation between 2003 and 2017 at a single institution were evaluated for occurrence of hepatic artery complications. HAS occurred in 37/454 (8%) of patients. HAS was defined as >50% stenosis on computed tomography or digital subtraction angiography. Hepatic arterial patency and graft survival were evaluated at annual intervals. Primary patency was defined as the time from revascularization to imaging evidence of new HAS or reaching a censored event (retransplantation, death, loss to follow-up, or end of study period). Primary stenting was attempted in 30 patients (17 female, 57%; median age, 51 years; range, 24-68 years). Surgical repair of HAS prior to stenting was attempted in 5/30 (17%) patients. Endovascular treatment was performed within 1 week of the primary anastomosis in 5/30 (17%) of patients. Technical success was accomplished in 97% (29/30) of patients. Primary patency was 90% at 1 year and remained unchanged throughout the remaining follow-up period (median, 41 months; interquartile range [IQR], 25-86 months). Reintervention was required in 3 patients to maintain stent patency. The median time period between primary stenting and retreatment was 5.9 months (IQR, 4.4-11.1 months). There were no major complications, and no patient developed hepatic arterial thrombosis or required listing for retransplantation or retransplantation during the follow-up period. In conclusion, primary stenting for HAS has excellent longterm primary patency and low reintervention rates.

摘要

最近的研究报告称,由于原发性通畅性丧失,原发性支架置入治疗肝动脉狭窄(HAS)后再干预率较高。本研究的目的是在一个长期随访的大队列中评估 HAS 后原发性支架置入的结果。经机构审查委员会批准,对 2003 年至 2017 年在一家机构接受肝移植的所有患者进行了肝动脉并发症发生情况的评估。37/454(8%)例患者发生 HAS。HAS 定义为 CT 或数字减影血管造影显示>50%狭窄。每年评估肝动脉通畅性和移植物存活率。原发性通畅性定义为血运重建至出现新 HAS 的影像学证据或达到截尾事件(再次移植、死亡、失访或研究结束)的时间。30 例患者(17 例女性,57%;中位年龄 51 岁;范围,24-68 岁)尝试进行原发性支架置入。5/30(17%)例患者尝试在支架置入前进行 HAS 手术修复。5/30(17%)例患者在原发性吻合术后 1 周内行血管内治疗。97%(29/30)例患者获得技术成功。1 年时原发性通畅率为 90%,在剩余的随访期间保持不变(中位数,41 个月;四分位距[IQR],25-86 个月)。为维持支架通畅性,3 例患者需要再次介入治疗。原发性支架置入和再次治疗之间的中位时间为 5.9 个月(IQR,4.4-11.1 个月)。无重大并发症发生,无患者发生肝动脉血栓形成或需要再次移植或再次移植。结论,HAS 的原发性支架置入具有极好的长期原发性通畅率和较低的再干预率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验